Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

by Oscier, David, Wade, Rachel, Davis, Zadie, Morilla, Alison, Best, Giles, Richards, Sue, Else, Monica, Matutes, Estella, Catovsky, Daniel
Published 2010

The outcome of chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with

by Davis, Zadie, Forconi, Francesco, Parker, Anton, Gardiner, Anne, Thomas, Peter, Catovsky, Daniel, Rose-Zerilli, Matthew, Strefford, Jonathan, Oscier, David
Published 2016

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

by Rose-Zerilli, Matthew J., Forster, Jade, Parker, Helen, Parker, Anton, Rodríguez, Ana E., Chaplin, Tracy, Gardiner, Anne, Steele, Andrew J., Collins, A., Young, Bryan D., Skowronska, Anna, Catovsky, Daniel, Stankovic, Tanja, Oscier, D.G, Strefford, Jonathan C.
Published 2014